Questioning Medicine
Questioning Medicine
Join Andrew on a medical rollercoaster as we ask a medical question and answer it based on recent published papers.
Be sure to visit the podcast's website and support the creator: www.podomatic.com
Author
Questioning Medicine
Category
Podcast website
Latest episode
Oct 21, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Episode 364: 364. The safety and efficacy of sodium–glucose cotransporter 2 inhibitor in hospitalized patients 04.02.2025 7:12
Gao FM et al. A systematic review and meta-analysis on the safety and efficacy of sodium–glucose cotransporter 2 inhibitor use in hospitalized patients. Diabetes Care 2024 Dec 1; 47:2275. ( https://doi.org/10.2337/dc24-0946 ) Trial Results SGLT-2 inhibitors, crucial in managing diabetes, kidney disease, and heart failure, have shown promising results in hospitalized patients 1 . The meta-analysi...
Episode 363: 262. Myocardial injury in patients with hip fracture 31.01.2025 5:58
Is accelerated surgery for hip fracture better for high-risk patients? A recent substudy of the HIP ATTACK trial has shed new light on this topic. The original trial, published in 2020, compared accelerated surgery (within 6 hours) to standard-timing surgery (within 24 hours) for hip fracture patients. While the initial results showed only marginal benefits, this new analysis focuses on a specif...
Episode 362: 261. What to do with the beta blocker following a Myocardial Infarction 15.01.2025 6:35
Today, we're discussing two groundbreaking studies from 2024 that challenge our understanding of β-blocker therapy for secondary prevention after myocardial infarction, or MI.Let's start with a Swedish study Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New England Journal of Medicine that included over 5,000 patients with normal left ventricular ejection fraction aft...
Episode 361: 260. METHODS MONDAY-- EVENT RATE 13.01.2025 10:28
Methods Monday --- Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review | Cardiology | JAMA Network Open | JAMA Network During the design of a randomized clinical trial (RCT), estimation of the expected event rate and effect size is a key component to calculating the sample size. Overly optimistic estimation of event rates and effect sizes may...
Episode 360: 259. Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients 10.01.2025 7:43
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821168 A team of researchers set out to change that by developing a comprehensive algorithm. The process involved a multidisciplinary panel of 11 expertss with extensive experience in managing urinary retention. These experts evaluated about 100 clinical scenarios to create an initial flow sheet. The algorithm was then refined through i...
Episode 359: 258. Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions 03.01.2025 5:55
https://jamanetwork.com/journals/jama/article-abstract/2822097 Design, Setting, and Participants Nested case-control study using population-based linked administrative datasets among adults aged 66 years or older who received at least 1 oral antibiotic between 2002 and 2022 in Ontario, Canada. Cases were those who had an emergency department (ED) visit or hospitalization for serious cADRs within...
Episode 358: 257. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention 30.12.2024 6:47
https://www.nejm.org/doi/full/10.1056/NEJMoa2407001 Conclusions No participants receiving twice-yearly lenacapavir acquired HIV infection. HIV incidence with lenacapavir was significantly lower than background HIV incidence and HIV incidence with F/TDF. Among 5338 participants who were initially HIV-negative, 55 incident HIV infections were observed: 0 infections among 2134 participants in the le...
Episode 357: 256. Medications for alcohol-use disorder and follow-up after hospitalization 27.12.2024 5:37
Allaudeen N et al. Medications for alcohol-use disorder and follow-up after hospitalization for alcohol withdrawal: A multicenter study. J Hosp Med 2024 Dec; 19:1122. ( https://doi.org/10.1002/jhm.13458 ) Hospital admission for alcohol withdrawal is a problem when it comes to readmission. They just come back--- In this retrospective study of ≈600 patients (96% men) admitted for alcohol wit...
Episode 356: 255. Real-world use of glucocorticoids for adults hospitalized with community-acquired pneumonia 23.12.2024 6:47
Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards - Malecki - 2024 - Journal of Hospital Medicine - Wiley Online Library This was a retrospective cohort study of 11,500 patients with CAP who were admitted to general medicine units in 7 Canadian hospitals, researchers compared outcomes for patients who received system...
Episode 355: 254. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension 20.12.2024 8:29
2024 ESC guidelines propose a simple new BP categorization: Non-elevated: less than 120/70 mm Hg in the office (pharmacological treatment is not recommended). Elevated: 120 to 139/70 to 89 mm Hg (pharmacological treatment is recommended for some, depending on cardiovascular disease [CVD] risk and follow-up BP measurements). Hypertension: 140/90 mm Hg or greater (confirmation and prompt pharmacolog...
Episode 354: 253. Centralized Colorectal Cancer Screening Outreach in Federally Qualified Health Centers 18.12.2024 7:08
Question Does adding centralized mailed fecal immunochemical testing and patient navigation to usual care improve colorectal cancer (CRC) screening in US federally qualified health centers? pragmatic randomized clinical trial was conducted Patients were enrolled and randomly assigned to usual care alone (control group) or intervention (2,001 participants per group). Intervention participants...
Episode 353: 252. 2.4 Million to Prevent 4 Hospitalizations! 13.12.2024 11:01
Packer M et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 2024 Nov 16; [e-pub]. https://doi.org/10.1056/NEJMoa2410027 In the industry-funded SUMMIT trial ( NCT04847557 ), investigators examined cardiovascular outcomes of tirzepatide — an agonist of glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors — over a longer period in pat...
Episode 352: 251. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease 12.12.2024 6:13
Wang Z et al. Safety of triptans in patients who have or are at high risk for cardiovascular disease: A target trial emulation. Mayo Clin Proc 2024 Nov; 99:1722. ( https://doi.org/10.1016/j.mayocp.2024.03.023 ) How unsafe are triptans triptans — the mainstays of migraine therapy — are vasoactive, the U.S. FDA considers them to be contraindicated in patients with cardiovascular (CV) disease or...
Episode 351: 250. STROKE part 3 CME 29.11.2024 9:11
STROKE part 3 CME
Episode 350: 249. STROKE - LA closure, alteplase vs tenecteplase, and thrombectomy 27.11.2024 17:36
CME FOR FREEE
Episode 349: 248. Stroke- UIA, CHAD-VASC, HAS-BLED, SPARC, PFO 26.11.2024 36:00
CME --- Stroke- UIA, CHAD-VASC, HAS-BLED, SPARC, PFO
Episode 348: 247. Early diagnostic paracentesis improves outcomes of hospitalized patients with cirrhosis and ascites 22.11.2024 6:08
Beran A et al. Early diagnostic paracentesis improves outcomes of hospitalized patients with cirrhosis and ascites: A systematic review and meta-analysis. Am J Gastroenterol 2024 Nov; 119:2259. ( https://doi.org/10.14309/ajg.0000000000002906 ) BOTTOM LINE (if you don’t like to read)- While it might not be fun to have the conversation with the ER provider saying you NEED A DIAGNOSTIC PARACENTESIS...
Episode 347: 246. Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk 21.11.2024 8:59
Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk: A Randomized Clinical Trial | Complementary and Alternative Medicine | JAMA Internal Medicine | JAMA Network In a randomized trial, acupuncture reduced pain and disability better than a sham procedure did. In this trial from China, 216 adults (mean age, 51) were randomized to undergo 10 sessions of acupuncture or sha...
Episode 346: 245. Duration of benefit and risk of dual antiplatelet therapy after mild ischemic stroke 20.11.2024 7:05
And now a secondary analysis of the trial focused on the timing of major ischemic events and the potential tradeoffs of benefits and risks,------ maybe there is magic sauce where the benefit is drastically greater than risk and vice versa! Guan L et al. Duration of benefit and risk of dual antiplatelet therapy up to 72 hours after mild ischemic stroke and transient ischemic attack. Neurology 202...
Episode 345: 244. CORRECTED ACOI question and answer 15.11.2024 16:37
The full podcast -- not sure why the last one cut off early. Question and answer from ACOI
Episode 344: 343. Arm position and blood pressure readings: The ARMS crossover randomized clinical trial 08.11.2024 5:09
Liu H et al. Arm position and blood pressure readings: The ARMS crossover randomized clinical trial. JAMA Intern Med 2024 Oct 7; [e-pub]. ( https://doi.org/10.1001/jamainternmed.2024.5213 ) study replicated some of the “real-world” shortcuts that often occur when we check BP, such as measuring BP while the patient is sitting up on an exam table.=== In this U.S. trial of 133 adults, researche...
Episode 342: 341. Methods Monday! What is the problem with stopping a trial EARLY? 04.11.2024 8:58
Stopping Trials Early for Benefit: Insights From Recent Pivotal Trials in Chronic Kidney Disease - ScienceDirect There are 4 major reasons why trials might be stopped early: 1) unequivocal benefit; 2) unacceptable harm; 3) futility; and 4) administrative reasons (enrollment or funding concerns). trials stopped early for benefit tend to overestimate benefit, a phenomenon referred to as ra...
Episode 341: 340. ACOI -- Vitamin D and Calcium Made Easy 30.10.2024 38:16
You get the CME knowledge without the CME payment!
Episode 340: 339. Reaction Risk to Direct Penicillin Challenges 29.10.2024 5:52
10% of hospitalized patients have penicillin allergy listed in their records, fewer than 1% of patients have true allergies. Use of more-expensive and broader-spectrum antibiotics is associated with longer and more-expensive hospital stays and more side effects, nosocomial infections, and resistant organisms. Blumenthal KG et al. Reaction risk to direct penicillin challenges: A systematic r...
Episode 339: 338. Hypertension Treatment With New Triple Single Pill Combination 25.10.2024 9:00
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension J Am Coll Cardiol 2024 Aug 30;[EPub Ahead of Print], A Rodgers, A Salam, AE Schutte, WC Cushman, HA de Silva, GL Di Tanna, D Grobbee, K Narkiewicz, DB Ojji, NR Poulter, MP Schlaich, S Oparil, W Spiering, B Williams, JT Wright, A Gutierez, A Sanni, P Lakshman, D McMulle...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.